ASA-KOR 81 mg Price

Overview

Welcome to Dwaey, specifically on ASA-KOR 81 mg page.
This medicine contains an important and useful components, as it consists of
Acetylsalicylic acid (Aspirin) is available in the market in concentration

Name

Drospirenone + Ethinylestradiol

Precaution

Drospirenone + ethinylestradiol is a combination oral contraceptive used for birth control, regulating menstrual cycles, and managing certain hormonal conditions. When prescribing this combination, it is important to consider specific precautions. It is contraindicated in women who have a **history of blood clots**, **stroke**, or **heart disease**, as the combination can increase the risk of thrombosis. Women who smoke, especially those over the age of 35, should be closely monitored, as smoking increases the risk of serious cardiovascular events in users of combined oral contraceptives. This medication should also be used with caution in patients with liver disease or impaired liver function, as the liver metabolizes the hormones in this combination. Additionally, patients with kidney disease, especially those with **renal impairment**, should use drospirenone with caution, as drospirenone can increase potassium levels, leading to **hyperkalemia**. Regular monitoring of potassium levels is recommended for patients with renal disease or those using other medications that may increase potassium. There are potential risks during pregnancy, and this combination should not be used during pregnancy or in women who are breastfeeding due to the potential effects on milk production and infant development. Patients with a history of **migraines** or **high blood pressure** should be monitored for any exacerbation of these conditions while using this medication.

Indication

The primary indication for **drospirenone + ethinylestradiol** is **contraception**. This combination is highly effective in preventing pregnancy by inhibiting ovulation, thickening cervical mucus to prevent sperm entry, and altering the endometrium to prevent implantation. It is a commonly prescribed option for women seeking an oral contraceptive method. In addition to contraception, **drospirenone + ethinylestradiol** is also indicated for the treatment of **moderate acne vulgaris** in females who are at least 14 years old and have started menstruating. It is also used to manage **symptoms of premenstrual dysphoric disorder (PMDD)** and to regulate **menstrual cycles** in women with irregular periods or anovulatory cycles. Off-label, drospirenone + ethinylestradiol may be prescribed for the management of **polycystic ovary syndrome (PCOS)**, **hirsutism**, or for **endometriosis**-related symptoms, though these uses should be discussed with a healthcare provider, as there may be more targeted treatment options available.

Contra indication

There are several conditions that contraindicate the use of **drospirenone + ethinylestradiol**. This combination should not be used in women who have a **history of blood clots (deep vein thrombosis or pulmonary embolism)**, **stroke**, **heart disease**, or other cardiovascular conditions, as the hormones in this combination may increase the risk of thromboembolic events. It is also contraindicated in women with **liver disease**, **active liver tumors**, or a history of **liver cancer**, as the liver metabolizes both hormones, and impaired liver function could affect drug metabolism and increase the risk of side effects. Other contraindications include **breast cancer**, **estrogen-sensitive cancers**, or other hormone-sensitive conditions, as both hormones can stimulate the growth of certain cancers. Women who are **pregnant** or **breastfeeding** should avoid this medication, as it may harm the fetus or infant. Women with **uncontrolled hypertension**, **diabetes with complications**, or **migraines with aura** should not use this combination due to the increased risk of cardiovascular events. Additionally, it should be avoided in individuals with **severe renal impairment**, as drospirenone can affect potassium levels, leading to **hyperkalemia**.

Side Effect

The side effects of **drospirenone + ethinylestradiol** vary depending on the individual, but the most common side effects include: - **Nausea** and **vomiting**: These are common during the first few months of use, although they often resolve as the body adjusts to the hormones. - **Headaches**, **mood changes**, and **depression**: Hormonal fluctuations can lead to changes in mood, irritability, or headaches. Some individuals may experience more severe mood disturbances or depressive symptoms. - **Breast tenderness** or **swelling**: Hormonal contraceptives can cause changes in breast tissue, leading to discomfort. - **Spotting** or **breakthrough bleeding**: Irregular bleeding, particularly during the first few months, is common but often resolves over time. - **Weight changes**: Some users may experience weight gain due to fluid retention or changes in appetite, though this is not universally reported. - **Blood clot risk**: The combination increases the risk of **deep vein thrombosis (DVT)**, **pulmonary embolism (PE)**, and **stroke**, particularly in women who smoke or have underlying cardiovascular risk factors. Less common but more serious side effects include **liver problems**, **gallbladder disease**, **hypertension**, and **changes in vision**. It is essential to monitor for any signs of **thromboembolic events** (leg pain, swelling, difficulty breathing, chest pain), which require immediate medical attention.

Pregnancy Category ID

5

Mode of Action

Drospirenone + ethinylestradiol works through a combination of **progestin** and **estrogenic** effects. **Ethinylestradiol**, a synthetic estrogen, primarily inhibits the release of **follicle-stimulating hormone (FSH)** and **luteinizing hormone (LH)**, thereby preventing ovulation. It also alters the endometrial lining to make it less receptive to implantation and thickens the cervical mucus, which reduces sperm motility and access to the egg. **Drospirenone**, a synthetic progestin, has unique properties compared to other progestins. It has **anti-mineralocorticoid** effects, meaning it can reduce water retention and **potassium-sparing** effects, which may be beneficial for women prone to fluid retention. This also leads to a lower risk of weight gain and bloating compared to other progestins. Drospirenone also has **anti-androgenic** effects, which help reduce **acne** and **hirsutism** (excessive hair growth) in women. The combination of these two hormones works synergistically to provide effective contraception, regulate menstrual cycles, and treat conditions like **PCOS**, **acne**, and **PMDD**.

Interaction

**Drospirenone + ethinylestradiol** has several significant drug-drug interactions that can impact its efficacy or cause unwanted side effects: - **Antibiotics**: Certain antibiotics, particularly **rifampin** and other **enzyme inducers**, can reduce the effectiveness of oral contraceptives by increasing their metabolism. It is recommended to use additional non-hormonal contraception during antibiotic treatment. - **Anticonvulsants**: Drugs such as **phenytoin**, **carbamazepine**, and **phenobarbital** may decrease the efficacy of this combination by increasing the breakdown of ethinylestradiol in the liver. - **Antifungal agents**: **Griseofulvin** and some **azole antifungals** (e.g., **ketoconazole**) can increase the risk of side effects, including thromboembolic events, by affecting the metabolism of the hormones in this combination. - **HIV medications**: **Ritonavir**, **lopinavir**, and other protease inhibitors can interfere with the efficacy of hormonal contraceptives. - **Medications that increase potassium levels**, such as **ACE inhibitors**, **ARBs**, or **potassium-sparing diuretics**, can interact with drospirenone, leading to **hyperkalemia**. It is important to avoid smoking while using drospirenone + ethinylestradiol, as smoking increases the risk of cardiovascular side effects, particularly in women over 35. Additionally, grapefruit juice may increase the concentration of the drug in the body, potentially leading to more side effects.

Pregnancy Category Note

Information not available

Adult Dose

For contraception, the typical dosage of **drospirenone + ethinylestradiol** is one tablet daily, taken at the same time each day. The dosage is typically a combination of **drospirenone 3 mg** and **ethinylestradiol 0.03 mg**. The pack usually consists of 21 active tablets and 7 inactive (placebo) tablets, with the active tablets taken for 21 days followed by a 7-day break during which withdrawal bleeding occurs. It is important to start the medication on the first day of the menstrual cycle or the first Sunday after the onset of menstruation. If starting at another time, additional contraceptive measures (e.g., condoms) should be used for the first 7 days.

Child Dose

This medication is not typically recommended for children. It is generally prescribed to women of reproductive age, starting from adolescence (age 12 or older) once they have reached menarche. The dosage for **drospirenone + ethinylestradiol** in adolescents is the same as in adults, but care should be taken to monitor for side effects such as **mood disturbances**, **weight changes**, and **irregular bleeding**. Use in younger populations should always be guided by a healthcare provider based on individual needs and health status.

Renal Dose

For women with **mild to moderate renal impairment**, no dose adjustment is necessary for **drospirenone + ethinylestradiol**. However, in patients with **severe renal impairment**, especially those with **creatinine clearance less than 30 mL/min**, drospirenone should be used cautiously. In such cases, **potassium levels** should be closely monitored, as drospirenone may cause **hyperkalemia**.

Administration

Information not available